Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
The New England Journal of Medicine
|
March 21, 2003
PR interval and the response to enzyme-replacement therapy for Fabry's disease
Stephen Waldek
European Journal of Clinical Pharmacology
|
July 9, 2015
It is time to review how unlicensed medicines are used
Adam Sutherland, Stephen Waldek
BMC Nephrology
|
June 3, 2014
Fabry nephropathy: a review - how can we optimize the management of Fabry nephropathy?
Stephen Waldek, Sandro Feriozzi
Molecular Genetics and Metabolism
|
June 19, 2012
Enzyme replacement therapy improves cardiac features and severity of Fabry disease
Manish Motwani, Sanjay Banypersad, Peter Woolfson, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
December 8, 2009
Biomarkers of Fabry disease nephropathy
Raphael Schiffmann, Stephen Waldek, Ariela Benigni, et al.
Lancet (London, England)
|
May 4, 2010
Enzyme replacement therapy for Fabry's disease
Stephen Waldek, Dominique P Germain, Christoph Wanner, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
September 12, 2009
Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry
Stephen Waldek, Manesh R Patel, Maryam Banikazemi, et al.
Journal of Renal Care
|
May 24, 2008
Milk alkali syndrome associated with excessive ingestion of Rennie: case reports
Ayesha Irtiza-Ali, Stephen Waldek, Elizabeth Lamerton, et al.
Muscle & Nerve
|
November 11, 2009
Corneal confocal microscopy: a novel noninvasive means to diagnose neuropathy in patients with Fabry disease
Mitra Tavakoli, Andrew Marshall, Lorraine Thompson, et al.
Nature Clinical Practice. Nephrology
|
April 24, 2008
Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults
Alberto Ortiz, João P Oliveira, Christoph Wanner, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
The New England Journal of Medicine
|
March 21, 2003
PR interval and the response to enzyme-replacement therapy for Fabry's disease
Stephen Waldek
European Journal of Clinical Pharmacology
|
July 9, 2015
It is time to review how unlicensed medicines are used
Adam Sutherland, Stephen Waldek
BMC Nephrology
|
June 3, 2014
Fabry nephropathy: a review - how can we optimize the management of Fabry nephropathy?
Stephen Waldek, Sandro Feriozzi
Molecular Genetics and Metabolism
|
June 19, 2012
Enzyme replacement therapy improves cardiac features and severity of Fabry disease
Manish Motwani, Sanjay Banypersad, Peter Woolfson, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
December 8, 2009
Biomarkers of Fabry disease nephropathy
Raphael Schiffmann, Stephen Waldek, Ariela Benigni, et al.
Lancet (London, England)
|
May 4, 2010
Enzyme replacement therapy for Fabry's disease
Stephen Waldek, Dominique P Germain, Christoph Wanner, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
September 12, 2009
Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry
Stephen Waldek, Manesh R Patel, Maryam Banikazemi, et al.
Journal of Renal Care
|
May 24, 2008
Milk alkali syndrome associated with excessive ingestion of Rennie: case reports
Ayesha Irtiza-Ali, Stephen Waldek, Elizabeth Lamerton, et al.
Muscle & Nerve
|
November 11, 2009
Corneal confocal microscopy: a novel noninvasive means to diagnose neuropathy in patients with Fabry disease
Mitra Tavakoli, Andrew Marshall, Lorraine Thompson, et al.
Nature Clinical Practice. Nephrology
|
April 24, 2008
Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults
Alberto Ortiz, João P Oliveira, Christoph Wanner, et al.
Page
of 4